High-Efficacy Disease-Modifying Therapies in People with Relapsing–Remitting Multiple Sclerosis: The Role of Risk Attitude in Treatment Decisions

被引：0
|
作者：
Jorge Maurino
Javier Sotoca
Ángel P. Sempere
Luis Brieva
Carlos López de Silanes
Ana B. Caminero
María Terzaghi
Julia Gracia-Gil
Gustavo Saposnik
机构：
[1] Roche Farma,Medical Department
[2] Hospital Universitari Mútua de Terrassa,Department of Neurology
[3] Hospital General Universitario de Alicante,Department of Neurology
[4] Hospital Universitari Arnau de Vilanova,Department of Neurology
[5] Hospital Universitario de Torrejón,Department of Neurology
[6] Complejo Asistencial de Ávila,Department of Neurology
[7] University of Toronto,Decision Neuroscience Unit, Li Ka Shing Institute
[8] Complejo Hospitalario Universitario de Albacete,Department of Neurology
[9] University of Toronto,Division of Neurology, Department of Medicine, St. Michael’s Hospital
[10] University of Zurich,Laboratory for Social and Neural System Research, Department of Economics
来源：
The Patient - Patient-Centered Outcomes Research | 2021年 / 14卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：241 / 248
页数：7
相关论文
共 50 条
  • [41] The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
    Marco Biolato
    Assunta Bianco
    Matteo Lucchini
    Antonio Gasbarrini
    Massimiliano Mirabella
    Antonio Grieco
    CNS Drugs, 2021, 35 : 861 - 880
  • [42] Disease-Modifying Therapies for Relapsing-Remitting Multiple Sclerosis: A Network Meta-Analysis
    Lucchetta, Rosa C.
    Tonin, Fernanda S.
    Borba, Helena H. L.
    Leonart, Leticia P.
    Ferreira, Vinicius L.
    Bonetti, Aline F.
    Riveros, Bruno S.
    Becker, Jefferson
    Pontarolo, Roberto
    Fernandez-Llimos, Fernando
    Wiens, Astrid
    CNS DRUGS, 2018, 32 (09) : 813 - 826
  • [43] The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review
    Biolato, Marco
    Bianco, Assunta
    Lucchini, Matteo
    Gasbarrini, Antonio
    Mirabella, Massimiliano
    Grieco, Antonio
    CNS DRUGS, 2021, 35 (08) : 861 - 880
  • [44] Escalating to medium- versus high-efficacy disease modifying therapy after low-efficacy treatment in relapsing remitting multiple sclerosis
    Mueller, Jannis
    Roos, Izanne
    Kalincik, Tomas
    Lorscheider, Johannes
    Galli, Edoardo
    Benkert, Pascal
    Schaedelin, Sabine
    Sharmin, Sifat
    Einsiedler, Maximilian
    Haenni, Peter
    Schmid, Juerg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Ziemssen, Tjalf
    Siepmann, Timo
    Yaldizli, Oezguer
    BRAIN AND BEHAVIOR, 2024, 14 (05):
  • [45] Effect of high-efficacy disease-modifying treatment on spinal cord lesion development in multiple sclerosis
    Kreiter, D.
    Spee, R.
    Merry, A.
    Hupperts, R.
    Gerlach, O.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 540 - 540
  • [46] Effect of initial high-efficacy disease modifying therapy in relapsing-remitting multiple sclerosis: a nationwide cohort study
    Buron, M. D.
    Chalmer, T. A.
    Barzinji, I.
    Christensen, J. R.
    Christensen, M. K. B.
    Hansen, V.
    Illes, Z.
    Jensen, H. B.
    Kant, M.
    Petersen, T.
    Rasmussen, P. V.
    Schafer, J.
    Sellebjerg, F.
    Theodorsdottir, A.
    Weglewski, A.
    Sorensen, P. S.
    Magyari, M.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 512 - 513
  • [47] High-efficacy disease-modifying therapies despite clinical stability: the role of patients on treatment decisions (PERCEPTIONS-MS Study)
    Saposnik, G.
    Sempere, A. P.
    Aladro-Benito, Y.
    Sotoca, J.
    Bakdache, F.
    Terzaghi, M.
    Maurino, J.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 800 - 800
  • [48] Disease-modifying therapy in adult relapsing-remitting multiple sclerosis
    Rosenzweig, Tamara M.
    Hartman, Sarah
    MacKenzie, Elizabeth
    FORMULARY, 2010, 45 (08) : 252 - 262
  • [49] Established disease-modifying treatments in relapsing-remitting multiple sclerosis
    Oh, Jiwon
    O'Connor, Paul W.
    CURRENT OPINION IN NEUROLOGY, 2015, 28 (03) : 220 - 229
  • [50] The Shifting Landscape of Disease-Modifying Therapies for Relapsing Multiple Sclerosis
    Burton, Jodie M.
    Freedman, Mark S.
    JOURNAL OF NEURO-OPHTHALMOLOGY, 2018, 38 (02) : 210 - 216
12345